The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k)…
Le test qualitatif cobas SARS-CoV-2 est l'un des premiers tests PCR COVID-19 effectués sur une plateforme automatisée à haut débit…
(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — Na luta contra o vírus SARS-CoV-2, um grande número de empresas…
(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — En la lucha contra el virus SARS-CoV-2, una gran cantidad de…
(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of…
(PRESS RELEASE) LIVERPOOL, 25-Jan-2021 — /EuropaWire/ — University of Liverpool announces that its has joined a consortium to develop new…
Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating…
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been…
(PRESS RELEASE) LONDON/ PARIS, 8-Jul-2020 — /EuropaWire/ — Digital transformation leader Atos has announced it will launch global HPC, AI…
(PRESS RELEASE) GHENT, 12-May-2020 — /EuropaWire/ — Fujirebio Europe, part of Japanese in vitro diagnostics (IVD) testing leader Fujirebio, has…